Search / Trial NCT06225440

Impact of Levagen+® Palmitoylethanolamide (PEA) in a Cross-Over Trial Examining Stress and Cognition in University Students

Launched by UNIVERSITY OF WESTMINSTER · Jan 24, 2024

Trial Information

Current as of December 21, 2024

Completed

Keywords

Nutraceutical Palmitoylethanolamide Pea Cognition Stress Inflammation Wellness Well Being Bdnf Supplement

ClinConnect Summary

The study will investigate the effect of Levagen+® Palmitoylethanolamide (PEA) supplementation on parameters of stress, well-being and cognition at defined time points. Assessments will be made using a combination of a range of stress measures, which will include physiological and psychometric parameters.

Physiological measures will include assessments of known biomarkers of the principal stress-sensitive physiological systems, the hypothalamic-pituitary-adrenal axis, and the autonomic nervous system, while psychometric measures will include established instruments to assess general health...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Males \& Females
  • 18 to 40 years of age
  • Fully enrolled full-time university students from London
  • Exclusion Criteria:
  • Consumption of \>14 servings of alcohol/week
  • Any learning disability (e.g. dysphasia)
  • Any neurobiological disorders (e.g. autism)
  • Smokers Any allergies/health issues related to items being ingested
  • Any serious illnesses or those on chronic medication
  • Any pregnant or lactating women
  • Any woman who is trying to conceive
  • Any chronic gastrointestinal disorders
  • Any chronic menstrual disorders (e.g. PCOS)
  • Any subjects who have undergone menopause or undergoing the perimenopause transition
  • Any eating disorders
  • Any depression/mental disorders
  • Any obese sedentary (not physically active) individual, according to BMI values
  • Any abnormal blood pressure levels
  • Shift work

Trial Officials

Mohammed Gulrez Zariwala, PhD

Principal Investigator

University of Westminster

Sanjoy Deb, PhD

Principal Investigator

Anglia Ruskin University

About University Of Westminster

The University of Westminster is a leading UK institution dedicated to advancing knowledge and improving health outcomes through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its diverse expertise to conduct rigorous and ethically sound studies. The institution is committed to addressing pressing health challenges, fostering a culture of scientific inquiry, and translating research findings into real-world applications. By engaging with local and global communities, the University of Westminster aims to contribute significantly to the enhancement of public health and the development of effective therapeutic interventions.

Locations

London, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0